Please ensure Javascript is enabled for purposes of website accessibility

Body Camera Battle Heats Up: TASER International Standing Up To VieVu's NYPD Win

By Travis Hoium - Oct 17, 2016 at 2:20PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

TASER International has offered 1,000 free body cameras to the NYPD in an effort to win favor after a competitor won a big contract with the department.

Axon body cameras are a key business for TASER International, and the loss of a contract with the NYPD brought up big fears for investors. Image source: TASER International. 

TASER International (AXON 5.64%) isn't taking its loss of a body camera contract with the NYPD to competitor Vievu, a subsidiary of Safariland Group, lightly. The company is challenging the NYPD's agreement with Vievu and offering 1,000 body cameras for field testing with the department. The battle over the country's largest police force could tell where both companies are headed in the future.

Image source: TASER International.

The NYPD's free body cameras

After Vievu won the contract to supply 1,000 body cameras and five years of cloud storage to the NYPD, TASER International went into panic mode. Shares dropped the next day, and management started trying to challenge the Vievu product as lacking field tests by the department. 

To show off its product, TASER is offering 1,000 body cameras for field testing -- an offer that Vievu has matched -- allowing the NYPD to compare the products side by side. It's a strategy that will either prove that TASER International has a superior offering, or that Vievu's price of one-third of what TASER bid is a much better value. 

What TASER International is hoping the NYPD sees

According to The New York Times, Cincinnati tested both TASER International and Vievu body cameras earlier this year, deciding on TASER International after finding the audio, video, and field of vision on Vievu cameras to be lower quality. And it's quality the company hopes the NYPD appreciates. 

TASER International's Axon 2 camera easily beats Vievu's LE4 in field of view, with 142 degrees compared to 95 degrees. And Vievu's software systems were found by Cincinnati to be lower quality, a concern after Oakland's Vievu system lost about a quarter of its data in a software upgrade. 

It's easy to see that TASER's Axon line may be better than Vievu, but at what cost? Reports were that TASER's bid was three times Vievu's, and it's likely some law enforcement agencies will see the lower cost as a big advantage. 

TASER International could compete by touting its superior performance, which it is hoping to do with the NYPD, but it may have to lower prices if this trend continues. 

Competitors are coming for TASER International's most important business

It's clear that Vievu has struck a cord with TASER International, and the battle between the two will be worth watching. The upstart may force TASER to lower prices, leading to lower margins and profits in the future. Or the Taser and body camera giant may be content with losing some market share in cities that value cost over quality. 

How TASER International reacts and whether or not the NYPD changes its decision on Vievu's contract could tell us where TASER's stock will go from here. If Vievu is a competitor that will take a significant share of the market, investors should be very concerned. But if TASER International proves to have a better product and can maintain high prices, it'll validate a bullish stance on the stock. The next few months could tell us where this battle over body cameras is headed. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Axon Enterprise Stock Quote
Axon Enterprise
AXON
$96.16 (5.64%) $5.13

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.